Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Novelix Pharmaceuticals had annual revenue of 307.34M INR with 583.80% growth. Novelix Pharmaceuticals had revenue of 208.61M in the quarter ending March 31, 2025, with 2,129.83% growth.

• Revenue: 307.34M
• Revenue Growth: +583.80%
• P/S Ratio: 1.78
• Revenue / Employee: 38.42M
• Employees: 8
• Market Cap: 545.86M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	307.34M	262.40M	583.80%
Mar 31, 2024	44.95M	25.74M	134.06%
Mar 31, 2023	19.20M	-69.92M	-78.45%
Mar 31, 2022	89.13M	-6.72M	-7.01%
Mar 31, 2021	95.85M	-12.58M	-11.60%